ARCHIVES

DCT To Renegotiate Cooperative Groups Term Of Award, Considering Other Major Changes

This article is from The Cancer Letter archive.

Vol. 14 No. 10 | March 4, 1988

Download PDF Visit The Full Archive

Related Articles

News Analysis: Filing Will Ignite Complex Litigation Costing Millions, With Uncertain Rewards

March 9, 2012

Clinical Trials Approved By NCI In November

December 28, 2001

FDA Clears Avastin-Interferon Combination In Renal Cancer; Interferon Role Undefined.

August 7, 2009

Stanford Group Working To Build ‘Superhighway’ To Synthesis Of Taxol

May 15, 1992

Phase III BETH Study Combining Avastin And Herceptin Open For Enrollment

June 27, 2008

Whole Brain Radiation Raises Risk Of Memory Problems

September 26, 2008